News
BGPartner advises Lalique Group SA on the organization of its Annual General Meeting 2024
10. July 2024
After successfully advising Lalique Group SA (securities symbol: LLQ), which is listed on the SIX Swiss Exchange, on the organization of its Annual General Meeting and the adaptation of its Articles of Association to the new Swiss Stock Corporation Act last year, BGPartner was also able to support the company at this year's Annual General Meeting. The Annual General Meeting was held on June 29, 2024 at The Dolder Grand in Zurich and was attended by over 300 shareholders, who approved all of the proposals put forward by the Board of Directors. Among other things, the Annual General Meeting also voted on the delisting of the company's shares from the SIX Swiss Exchange.
The BGPartner team consisted of Dr. Alain P. Röthlisberger (Partner, Team Lead), Oliver Gnehm (Partner) and David Dalla Veccia (Senior Associate). BGPartner has proven expertise in the areas of corporate and commercial law (including corporate governance and capital markets law issues) as well as M&A and private equity and regularly advises national and international public companies, their boards of directors, investors and shareholders as well as entrepreneurs from all industries.
24. Jazz Brunch
27. June 2024
The annual Jazz Brunch is as much a part of BGPartner as the negotiation competence or the different legal services. For the 24rd time over 240 guests enjoyed culinary delights, fantastic jazz music, great weather and a relaxed atmosphere on the Gurten Hill (Berne).
A big thank you to the Gurten - Park im Grünen crew under the leadership of Patrick Vogel for the smooth running of the event and the Imelda Gabs Jazz band, who has remained loyal to us over the years, despite her rising fame. Here you can find the photo gallery.
BGPartner advises Memo Therapeutics on extension of Series C financing to CHF 45 million
07. May 2024
BGPartner advised Memo Therapeutics Ltd, a late-stage biotech company developing a best-in-class BKV-neutralizing antibody for BKV infection in kidney transplantation, on the successful completion of its Series C extension financing. Memo Therapeutics Ltd raised a further CHF 20 million, bringing the total amount raised in this funding round to CHF 45 million. The Series C extension financing was led by Ysios Capital and Kurma Partners and was joined by existing investors.
The new funding will be used to bolster the clinical advancement of Memo Therapeutic’s lead asset, AntiBKV. There are more than 100,000 kidney transplants worldwide each year and 20,000 of these are at risk from developing BK virus associated nephropathy. With no disease modifying therapies available, there is an urgent need for a treatment. FDA fast track status has already been obtained.
BGPartner assisted Memo Therapeutics Ltd in all legal and negotiation matters in this transaction and is proud to have been advising Memo Therapeutics Ltd for several years already. The team was led by Oliver Gnehm (Partner) and consisted of Victoria Marty (Senior Associate) and Barbara Meise (Associate).
Click here for the complete media release.
More information about our legal and negotiation expertise can be found here.
Parallels between extreme sports and negotiations
31. January 2024
International sporting history was made with the breathtaking performance of the Kiwi Fondue Team in July 2023. The Kiwi Fondue Team broke the world record in the Pacific race World's Toughest Row.
Dr. Alain P. Röthlisberger and navigator Alexander Gammeter analyzed the race together in the second interview and compared the parallels between challenging negotiations and extreme sports.
Find out what else makes the Kiwi Fondue Team so successful in the detailed interview on YouTube.
Are you interested in the topic of negotiating? Then continue here.
Vis Moot Court Trial Round 2024
11. January 2024
The countdown is on. Once again this year, we are proud to host a Vis Moot Court Trial Round incl. Negotiation Add-on. On February 13, 2024, we will have the privilege of welcoming the teams from the following universities: Berne, Zurich, Lausanne and Geneva.
Negotiation skills are an integral part of BGPartner's DNA. Training in negotiation skills not only leads to better results in real life, but is also highly relevant for students for their future careers as successful lawyers.
In addition to the official Vis Moot Court Trial Round, BGPartner therefore offers an additional training round in which the teams can develop their negotiation skills. They will benefit directly from the input of our negotiation experts.
We look forward to seeing you there!